This seminar provided an overview of Liam’s PhD studies, beginning with a systematic review and meta-analysis of previously researched pharmacological treatments for methamphetamine withdrawal. It then proposed a novel treatment option, lisdexamfetamine, before reporting on the results of a novel clinical trial investigating the safety and feasibility of using lisdexamfetamine to treat acute methamphetamine withdrawal. This then followed by a brief look into how sleep is measured in substance use trials and the seminar concluded with a qualitative examination of clinical trial participants experiences during the above studies. [Duration 56 minutes]

About the speaker:

Liam is a PhD Candidate with the National Drug and Alcohol Research Centre (NDARC) and the National Centre for Clinical Research on Emerging Drugs (NCCRED), UNSW Sydney, and a Research Officer at the St. Vincent’s Hospital Sydney Alcohol and Drug Service. Liam’s work focuses on clinical trials of novel treatment options for stimulant use and withdrawal, and mixed methods clinical research investigating substance use, sleep and the experiences of people who use drugs interacting with health services.